As the psychedelic renaissance is marching on, more and more companies and investors are starting to look how to make profit on this newly emerging field in the US and Canada. One of these companies is Filament Health. In a recent article published on Psychedelic Spotlight, they are proud to announce the coming Phase 1 clinical trials for their freshly processed, newly created, standardized Ayahuasca pill. Continue reading “Ayahuasca pill & cultural appropriation”

Join our communitysign up for our mailing list
Heart Medicine